RADOIR is ranked alongside the active members of the Stakeholder Information Bank for EMA.
- RADOIR NEWS- The European Medicine Agency (EMA) was established in 1995 in London. Its support and services in line with the Sustainable Development Goals are as per followings:
- To provide facility to develop pharmaceutical affairs, support access to orphan drugs and also projecting the scientific and pharmaceutical researches to support the rare diseases through EMA’s expertise scientific Committee
- To review the safety of drugs, especially their expiration date, and the impact on rare diseases public procedure
- To present the annual report on the development of orphan drugs all over the world, especially in Europe.
EMA’s partners: WHO, World Health Organization, EDQM, European Directory for the Quality of Medicines (ICH), International Council on Harmonization of the technical requirements for the registration of Pharmaceuticals for the Human use (ICMRA), International Coalition of Medicines Regulatory Authorities (IGDRP), International Generic Drug Regulators Program International Pharmaceutical Regulators Forum (IPRF).
Rare Diseases Foundation of Iran scientific and pharmaceutical intends to join this congress.